London & Capital Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,052
| Closed | -$1.05M | – | 102 |
|
|
2025
Q1 | $1.05M | Sell |
27,052
-14,738
| -35% | -$571K | 0.09% | 74 |
|
|
2024
Q4 | $1.41M | Buy |
41,790
+167
| +0.4% | +$5.65K | 0.12% | 66 |
|
|
2024
Q3 | $1.7M | Buy |
41,623
+568
| +1% | +$23.2K | 0.13% | 60 |
|
|
2024
Q2 | $1.58M | Buy |
41,055
+3,989
| +11% | +$154K | 0.13% | 58 |
|
|
2024
Q1 | $1.59M | Buy |
37,066
+4,046
| +12% | +$173K | 0.12% | 57 |
|
|
2023
Q4 | $1.22M | Buy |
33,020
+3,883
| +13% | +$144K | 0.1% | 59 |
|
|
2023
Q3 | $1.06M | Buy |
29,137
+3,588
| +14% | +$130K | 0.1% | 57 |
|
|
2023
Q2 | $911K | Buy |
+25,549
| New | +$911K | 0.09% | 56 |
|